Business and Industry
Lucid News
2024-01-21
APPA’s Stephen Xenakis Discusses the Future of Psychedelic Therapy
The executive director of the American Psychedelic Practitioners Association shares his vision for the professionalization of psychedelic-assisted therapy, as FDA approval seems likely this year.
Share:
Related News
Psychedelic Science 2025: Set and (Re)Setting
For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and some noticeable shifts in the psychedelic space. After the usual chaos of delayed flights and travel drama on Tuesday, we shared a collective sigh of relief as we finally arrived at the Colorado Convention Center, a mile high and ready to dive in.
Read More
Mindstate Uses AI to Design “Next-Gen” Psychedelics Combined With 5-MeO-MiPT
Mindstate Design Labs has received approval for a Phase 1 clinical trial to investigate the use of its formulation of 5-MeO-MiPT which it hopes to combine with other drugs to target precise serotonin receptors and create future psychotropic therapies.
Read More